SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-001698
Filing Date
2023-01-13
Accepted
2023-01-13 19:30:32
Documents
1
Period of Report
2023-01-12

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3808
  Complete submission text file 0001140361-23-001698.txt   5469
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10531 4S COMMONS DRIVE SUITE 160-550 SAN DIEGO CA 92127
Business Address
Angel Matthew (Reporting) CIK: 0001931356 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 23529954